Report by the Industrial Injuries Advisory Council in Accordance with Section 171 of the Social Security Administration Act 1992 Marking the Completion of the Review of the Scheduled List of Prescribed Diseases
Report by the Industrial Injuries Advisory Council in Accordance with Section 171 of the Social Security Administration Act 1992 Marking the Completion of the Review of the Scheduled List of Prescribed Diseases
The Industrial Injuries Advisory Council's (IIAC) review of the list of prescribed diseases for which Industrial Injuries Disablement Benefit is payable first began in 1997. Reports of comprehensive reviews of a number of particular diseases have been published since then (Command papers Cm 4280, 5395, 5672, 5997, 6098, 6553, 6645, 6867, 6868). Each prescribed disease has now been reviewed and this report contains a summary of the key findings of the comprehensive reviews. Certain prescribed diseases did not warrant full review, and the Committee also considered several other occupational diseases for prescription, and the findings in relation to both these categories are presented here. Numerous amendments have been made to the list, to ensure the statutory requirements continue to be satisfied and the schedule remains up-to-date in light of current scientific knowledge.
This report contains recommendations by the Industrial Injuries Advisory Council for extensive changes to the prescription of diseases caused by occupational exposure to chemicals. Recommendations include that the terms of prescription be reworded for 24 diseases; and that six diseases be removed from the schedule. In the course of the review, the Council identified a need for detailed examination of several other disorders that might be eligible for prescription in relation to exposure to chemicals. It intends to undertake an investigation of these disorders as a separate exercise in the near future.
report by the Industrial Injuries Advisory Council in accordance with section 171 of the Social Security Administration Act 1992 reviewing the prescription of chronic obstructive pulmonary disease (COPD) - chronic bronchitis and emphysema
report by the Industrial Injuries Advisory Council in accordance with section 171 of the Social Security Administration Act 1992 reviewing the prescription of chronic obstructive pulmonary disease (COPD) - chronic bronchitis and emphysema
The Industrial Injuries Advisory Council (IIAC) has completed a review of occupational coverage for the prescribed disease chronic bronchitis and emphysema (now encompassed by the term chronic obstructive pulmonary disease (COPD)). Following reviews of the literature, consultation with experts in several areas, consideration of reviews commissioned by independent academic bodies and public consultation, the Council recommends that the current terms of prescription remain for chronic bronchitis and emphysema in underground coal workers, for byssinosis in cotton workers, and for emphysema in workers exposed to cadmium fume. It recommends an extension for chronic bronchitis and emphysema to include exposure to coal dust in screen workers employed at the surface of coal mines. Workers should have been employed for the equivalent of 40 years and qualifying exposures should have occurred before 1983. IIAC has also considered prescription for other occupational groups including cotton textile workers, welders, grain workers and workers exposed to silica or isocyanates. There was insufficient evidence to recommend prescription or amendment to prescription for any other occupational categories, but the IIAC will continue to monitor emerging evidence.
Report by the Industrial Injuries Advisory Council in Accordance with Section 171 of the Social Security Administration Act 1992 Reviewing the Prescription of the Asbestos-related Diseases
Report by the Industrial Injuries Advisory Council in Accordance with Section 171 of the Social Security Administration Act 1992 Reviewing the Prescription of the Asbestos-related Diseases
This is the report of the review by the Industrial Injuries Advisory Council of the prescription of asbestosis, mesothelioma, lung cancer, pleural thickening and pleural plaques. Following reviews of the literature and consultations with experts and stakeholders the Council recommends a number changes to the terms of prescription for asbestos-related diseases
report by the Industrial Injuries Advisory Council in accordance with section 171 of the Social Security Administration Act 1992 considering prescription for osteoarthritis of the knee in carpet fitters and carpet and floor layers
report by the Industrial Injuries Advisory Council in accordance with section 171 of the Social Security Administration Act 1992 considering prescription for osteoarthritis of the knee in carpet fitters and carpet and floor layers
This review sets out the case for prescription for osteoarthritis of the knee in construction trades, including carpet fitters and carpet floor layers. The report follows the addition of OA of the knee to the list of prescribed diseases for coal miners and a subsequent scoping exercise in other occupations involving significant knee straining activity. The present review considered both the direct research evidence and the scope for combining direct and indirect research. In the event ample direct evidence was found that the risk of OA of the knee is more than doubled in those working for at least 20 years in aggregate as carpet fitters or carpet and floor layers. Accordingly the Industrial Injuries Advisory Council (IIAC) recommends prescription in these cases. For the purpose of the Industrial Injuries Disablement Benefit scheme a diagnosis of OA of the knee should be based on knee pain, swelling, stiffness and restricted movement and, if possible, x-ray evidence of stage 3-4 on the Kellgren-Lawrence scale, but should also be accepted in those who are on a surgical waiting list for knee replacement or have had knee replacement previously. By contrast the review suggests that direct evidence of risk of knee OA in other construction trades is sparse and far from compelling and the IIAC does not recommend prescription for those but will continue to monitor emerging evidence
Report by the Industrial Injuries Advisory Council in Accordance with Section 171 of the Social Security Administration Act 1992 Reviewing the Prescription of Extrinsic Allergic Alveolitis for Work Involving Exposure to Mists from Metalworking Fluids
Report by the Industrial Injuries Advisory Council in Accordance with Section 171 of the Social Security Administration Act 1992 Reviewing the Prescription of Extrinsic Allergic Alveolitis for Work Involving Exposure to Mists from Metalworking Fluids
Extrinsic allergic alveolitis (EEA) is a potentially serious respiratory disease caused by exposure to a variety of sensitising agents, and recently there have been three separate outbreaks of EEA reported in UK factories where workers were exposed to mists of metalworking fluids. EEA is already a prescribed disease in relation to several occupational exposures, and this review by the Industrial Injuries Advisory Council recommends its extension to include work involving exposure to mists generated during metalworking.
This Command Paper (Cm. 7415, ISBN 9780101741521) sets out the Government's ambition of helping people develop their skills so as to improve their prospects in the employment market. Skills development will become a condition when claiming out-of-work benefits. Individuals will also have access to a personal Skills Account, with advice, support and information available about training. Also the Government wants to promote a local based level of support from employers, which is already taking place via the Working Neighbourhoods Fund and City Strategy and Multi-Area Agreements (MAA). A new adult advancement and careers service is to be developed in England along with an integration of the welfare and skills services to respond to the needs and ambitions of both employers and individuals.
Report by the Industrial Injuries Advisory Council in Accordance with Section 171 of the Social Security Administration Act 1992 Reviewing the Prescription of the Asbestos-related Diseases
Report by the Industrial Injuries Advisory Council in Accordance with Section 171 of the Social Security Administration Act 1992 Reviewing the Prescription of the Asbestos-related Diseases
This is the report of the review by the Industrial Injuries Advisory Council of the prescription of asbestosis, mesothelioma, lung cancer, pleural thickening and pleural plaques. Following reviews of the literature and consultations with experts and stakeholders the Council recommends a number changes to the terms of prescription for asbestos-related diseases
Report by the Industrial Injuries Advisory Council in Accordance with Section 171 of the Social Security Administration Act 1992 Reviewing the Terms of Prescription for Cancers Due to Ionising Radiation Under the Industrial Injuries Scheme
Report by the Industrial Injuries Advisory Council in Accordance with Section 171 of the Social Security Administration Act 1992 Reviewing the Terms of Prescription for Cancers Due to Ionising Radiation Under the Industrial Injuries Scheme
report by the Industrial Injuries Advisory Council in accordance with section 171 of the Social Security Administration Act 1992 reviewing the prescription of chronic obstructive pulmonary disease (COPD) - chronic bronchitis and emphysema
report by the Industrial Injuries Advisory Council in accordance with section 171 of the Social Security Administration Act 1992 reviewing the prescription of chronic obstructive pulmonary disease (COPD) - chronic bronchitis and emphysema
The Industrial Injuries Advisory Council (IIAC) has completed a review of occupational coverage for the prescribed disease chronic bronchitis and emphysema (now encompassed by the term chronic obstructive pulmonary disease (COPD)). Following reviews of the literature, consultation with experts in several areas, consideration of reviews commissioned by independent academic bodies and public consultation, the Council recommends that the current terms of prescription remain for chronic bronchitis and emphysema in underground coal workers, for byssinosis in cotton workers, and for emphysema in workers exposed to cadmium fume. It recommends an extension for chronic bronchitis and emphysema to include exposure to coal dust in screen workers employed at the surface of coal mines. Workers should have been employed for the equivalent of 40 years and qualifying exposures should have occurred before 1983. IIAC has also considered prescription for other occupational groups including cotton textile workers, welders, grain workers and workers exposed to silica or isocyanates. There was insufficient evidence to recommend prescription or amendment to prescription for any other occupational categories, but the IIAC will continue to monitor emerging evidence.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.